|
Hopeful is very right about the HLA-DR15 thing. It's only one data point.
The Campath trial I was in (for MDS, not AA) used a combination of age and HLA-DR15 status to determine likelihood of response (based on some earlier research that parsed out all the statistics). And other studies have found other data points to be predictors.
You kind of have to mash it all together and see where you think you might stand and what's worth giving a shot.
Have a great weekend!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|